The Executive Master of Business Innovation & Entrepreneurship in LS&H A program by the Life Sciences & Health Academy ivzw

Transcription

1 The Executive Master of Business Innovation & Entrepreneurship in LS&H A program by the Life Sciences & Health Academy ivzw

2 Vision of Life Sciences & Health Academy Building a Global Training Ecosystem with Entrepreneurial Impact on the Life Sciences Industry

3 Why an Executive MBI? Need: Entrepreneurs in LS&H who are able to start & build a sustainable life science company Solution: An action based, interactive learning-on-the-job program that provides and applies new entrepreneurial skills & tools to grow LS&H ventures

4 Unique Selling Points of the MBI program Dedicated: Focused on executive teams of start-up/young growth companies in life sciences industry Excellence: Teaching at top business schools Value adding: Your own business is the permanent business case Coaching: on your case by industry experts International: build an international network (Netherlands, Flanders & Boston/California)

5 Action-based learning bringing the case to the next level

6 Structure of the program

7 Target audience for the program Entrepreneurs from valorization centers, start-ups and corporates Holding a master degree and have at least 3-5 years working experience Often a team composed of a science-driven and a business-driven profile Max. 14 teams in total

8 Program details The tuition fee is Euros (excl. VAT) per person excluding conferences, food costs, hotel accomodations and travel expenses. (working on a voucher system for small ventures per person reduction). Time investment: Average 2 days/month Start of the program: October, 15th 2015 Intake and screening participants: Jan 2015-June 2015 Expected number of participants: max. 28 (14 cases) End of the program: October, 28th 2016

9 Founding partners: Academic residence & quality assurance

10 Strategic Partners provide crucial support Build and sustain MBI Life Sciences & Health towards a leading program with global reach MBI LS&H Academy needs strategic partnerships from global, excellent life sciences & health organizations, investors & business schools Building a locally embedded source of high quality entrepreneurs First insights in new venture cases Life long learning by interacting: strong interfirm network best practices opportunities for future investments

11 MBI is building a very visble consortium of strategic partners Open invitation to expand

12 The advisory board Henri Termeer Clemens van Blitterswijk Hanno Cappon Johan Cardoen Rudi Dekeyser Joep de Groot Patrik de Haes Johan van Helleputte Hans Hofstraat Piet Houwen Henk Joos Roelof Konterman : Former CEO Genzyme Corporation : Prof. Tissue Regeneration Merln, Maastricht University :VP R&D Nutricia Medical Nutrition : Managing Director VIB, Board Member FlandersBIO : Managing Partner LSP Health Economics Fund : Board Member CbusineZ, Board of Directors CZ : CEO ThromboGenics, Chairman FlandersBIO : Senior Vice President Strategic Development IMEC : Vice President Philips Research : Head of Contract Manufacturing Operations Genzyme : CEO FlandersBIO : Member Executive Board Achmea

13 The advisory board Ton Logtenberg Frank Miedema Geert Jan Mulder Arno Nierich Rudi Pauwels Anton Pijpers Rob de Ree Pieter Rhemrev Paul Smits Pieter Wolters Chantal van der Zwan : CEO Merus : Dean Faculty of Medicine, Vice Chairman UMC Utrecht : General Partner Forbion Capital Partner : Anesthesiologist Intensivist, Head Innovation Isala Clinics : Founder and Executive Chairman Biocartis : Vice chairman Board of Utrecht University : CEO Dezima Pharma : PPM Oost NV, Life Sciences &Health : Dean and Vice Chairman Executive Board Radboudumc : Managing Director Venturing and Licensing DSM : PGGM Investments, Life Sciences Fund

14 We are looking forward to meeting you in the program! Visit us at